新近国内外幽门螺杆菌感染处理重要共识初次治疗内容对比解读

被引:14
作者
欧阳耀斌
李年双
谢川
吕农华
机构
[1] 南昌大学第一附属医院消化内科
关键词
幽门螺杆菌; 根除治疗; 共识; 抗生素耐药;
D O I
暂无
中图分类号
R573 [胃疾病];
学科分类号
100201 [内科学];
摘要
H.pylori是多种胃部疾病的重要致病因素, 但H.pylori的根除治疗面临着一些挑战, 主要为抗生素耐药。为规范H.pylori感染的诊治和提高H.pylori感染根除疗法的根除率, 国内外先后颁发了一系列共识。本文就《多伦多成人幽门螺杆菌感染治疗共识》《幽门螺杆菌感染处理Maastricht-Ⅴ共识》《幽门螺杆菌感染治疗美国胃肠病学院共识》与我国《第五次全国幽门螺杆菌感染处理共识报告》中H.pylori感染初次治疗的内容进行对比与解读。
引用
收藏
相关论文
共 15 条
[1]
Two-week bismuth-containing quadruple therapy and concomitant therapy are effective first-line treatments for Helicobacter pylori eradication: A prospective open-label randomized trial [J].
Kim, So Jeong ;
Chung, Jun-Won ;
Woo, Hyun Sun ;
Kim, Su Young ;
Kim, Jung Ho ;
Kim, Yoon Jae ;
Kim, Kyoung Oh ;
Kwon, Kwang An ;
Park, Dong Kyun .
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (46) :6790-6798
[2]
第五次全国幽门螺杆菌感染处理共识报告 [J].
中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组 ;
全国幽门螺杆菌研究协作组 ;
刘文忠 ;
谢勇 ;
陆红 ;
成虹 ;
曾志荣 ;
周丽雅 ;
陈烨 ;
王江滨 ;
杜奕奇 ;
吕农华 .
中华消化杂志, 2017, 37 (06)
[3]
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment [J].
Chen, Qi ;
Long, Xiaohua ;
Ji, Yingjie ;
Liang, Xiao ;
Li, Dongping ;
Gao, Hong ;
Xu, Beili ;
Liu, Ming ;
Chen, Ying ;
Sun, Yunwei ;
Zhao, Yan ;
Xu, Gang ;
Song, Yanyan ;
Yu, Lou ;
Zhang, Wei ;
Liu, Wenzhong ;
Graham, David Y. ;
Lu, Hong .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (11) :1385-1394
[4]
Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China [J].
Xie, Yong ;
Zhang, Zhenyu ;
Hong, Junbo ;
Liu, Wenzhong ;
Lu, Hong ;
Du, Yiqi ;
Wang, Weihong ;
Xu, Jianming ;
Wang, Xuehong ;
Huo, Lijuan ;
Zhang, Guiying ;
Lan, Chunhui ;
Li, Xiaoyan ;
Li, Yanqing ;
Wang, Hong ;
Zhang, Guoxin ;
Zhu, Yin ;
Shu, Xu ;
Chen, Ye ;
Wang, Jiangbin ;
Lu, Nonghua .
HELICOBACTER, 2018, 23 (05)
[5]
Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions.[J].Alessia Savoldi.Gastroenterology.2018,
[6]
Tu1295 - Systematic Review and Meta-Analysis: Concomitant Therapy Versus Triple Therapy for the First-Line Treatment of Helicobacter Pylori Infection.[J].Jyh-Ming Liou;Mei-Jyh Chen;Chieh-Chang Chen;Jaw-Town Lin;Ming-Shiang Wu.Gastroenterology.2018, 6S1
[7]
Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis [J].
Wang, Youhua ;
Zhao, Rulin ;
Wang, Ben ;
Zhao, Qiaoyun ;
Li, Zhen ;
Zhu-ge, Liya ;
Yin, Wenzhu ;
Xie, Yong .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (01) :1-13
[8]
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies [J].
Gisbert, Javier P. ;
McNicholl, Adrian G. .
HELICOBACTER, 2017, 22 (04)
[9]
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report [J].
Malfertheiner, P. ;
Megraud, F. ;
O'Morain, C. A. ;
Gisbert, J. P. ;
Kuipers, E. J. ;
Axon, A. T. ;
Bazzoli, F. ;
Gasbarrini, A. ;
Atherton, J. ;
Graham, D. Y. ;
Hunt, R. ;
Moayyedi, P. ;
Rokkas, T. ;
Rugge, M. ;
Selgrad, M. ;
Suerbaum, S. ;
Sugano, K. ;
El-Omar, E. M. .
GUT, 2017, 66 (01) :6-30
[10]
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults [J].
Fallone, Carlo A. ;
Chiba, Naoki ;
van Zanten, Sander Veldhuyzen ;
Fischbach, Lori ;
Gisbert, Javier P. ;
Hunt, Richard H. ;
Jones, Nicola L. ;
Render, Craig ;
Leontiadis, Grigorios I. ;
Moayyedi, Paul ;
Marshall, John K. .
GASTROENTEROLOGY, 2016, 151 (01) :51-+